2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond
One famous investing maxim advises to buy low and sell high. That's sage advice, but not all stocks are worth investing in while they are down. If they don't go up, you won't have profited from the advice.
Take, for instance, Aurora Cannabis (NASDAQ: ACB), a leader in the Canadian pot market, and Biogen (NASDAQ: BIIB), a notable biotech. Both have grabbed plenty of headlines in recent years, both have failed to keep pace with the market in 2023, and neither seems to have strong prospects.
Aurora Cannabis has consistently been one of the most talked-about stocks in the Canadian pot market since recreational adult use became legal some five years ago. However, the marijuana grower has also been a disappointment, with inconsistent revenue growth, persistent net losses, failure to partner with a larger company, and financial issues related to share dilution.
Source Fool.com
Biogen Inc. Stock
The stock is one of the favorites of our community with 45 Buy predictions and 2 Sell predictions.
With a target price of 294 € there is a positive potential of 43.91% for Biogen Inc. compared to the current price of 204.3 €.
